GI final drug cards

0.0(0)
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/310

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

311 Terms

1
New cards

adalimumab brand

humira

2
New cards

adalimumab class

TNF inhibitor

3
New cards

adalimumab MOA

binds and inhibits tumor necrosis factor alpha, reducing inflammation and altering immune response

4
New cards

adalimumab AEs

headache, rash, nausea, inj site reaction, hyperlipidemia, hematuria, elevation of ALK/CK, arthralgia

5
New cards

adalimumab contraindications

active infections

6
New cards

adalimumab dose

40 mg SC q2weeks

7
New cards

adalimumab BBW

increased risk of serious infections; lymphoma or other malignancies may also occur

8
New cards

etanercept brand

enbrel

9
New cards

etanercept class

Antirheumatic; Tumor Necrosis Factor (TNF) Blocking Agent

10
New cards

etanercept dose

SC: 50 mg once-twice weekly depending on disease state

11
New cards

etanercept BBW

- Patients receiving are at increased risk for serious infections which may result in hospitalization and/or fatality
- Lymphoma and other malignancies (some fatal) have been reported in children and adolescents receiving TNF-blocking agents, including etanercept.
- Active tuberculosis (disseminated or extrapulmonary), including reactivation of latent tuberculosis, has been reported in patients receiving etanercept

12
New cards

lubiprostone brand

amitiza

13
New cards

lubiprostone class

Gastrointestinal Agent, Chloride Channel Activator

14
New cards

lubiprostone dose

- Chronic idiopathic constipation PO: 24 mcg twice daily
- IBS with constipation females >18 yo PO: 8 mcg twice daily
- Opioid induced constipation PO: 24 mcg twice daily

15
New cards

lubiprostone contraindications

Syncope/hypotension

16
New cards

lactulose brand

constulose, enulose, gerelac, kristalose

17
New cards

lactulose class

Laxative, Ammonium Detoxicant

18
New cards

lactulose dose

Constipation PO: 10 to 20 grams per day up to (40g/day)

19
New cards

lactulose contraindications

Low galactose diet
Caution in patients with diabetes mellitus; solution contains galactose and lactose
Monitor periodically for electrolyte imbalance

20
New cards

diphenoxylate/atropine brand

lomotil

21
New cards

diphenoxylate/atropine class

Gastrointestinal, Antidiarrheal

22
New cards

diphenoxylate/atropine dose

PO: 5mg diphenoxylate component four times per day PRN (20mg/day max)

23
New cards

diphenoxylate/atropine contraindications

Obstructive jaundice; diarrhea associated with pseudomembranous enterocolitis

24
New cards

rifaximin brand

xifaxan

25
New cards

rifaximin class

Antibiotic, Rifamycin

26
New cards

rifaximin dose

- Hepatic encephalopathy PO: 550 mg twice per day
- Irritable bowel syndrome— diarrhea PO: 550 mg three times per day for 14 days
- Traveler's Diarrhea PO: 200 mg three times per day for 3 days

27
New cards

rifaximin contraindications

Potentially significant interactions may exist, requiring dose or frequency adjustment, additional monitoring, and/or selection of alternative therapy

28
New cards

potassium chloride brand

klor-con, micro-k

29
New cards

potassium chloride class

electrolyte

30
New cards

potassium chloride MOA

replaces potassium

31
New cards

potassium chloride AEs

nausea, vomiting, flatulence, abdominal discomfort, diarrhea

32
New cards

potassium chloride contraindications

hyperkalemia, delayed GI transit, GI obstruction

33
New cards

potassium chloride dose

20-25 mEq PO QD

34
New cards

potassium chloride BBW

none

35
New cards

vitamin D brand

ergocalciferol, cholecalciferol

36
New cards

vitamin D class

vitamin

37
New cards

vitamin D MOA

stimulates intestinal calcium and phosphate absorption, stimulates bone mineralization

38
New cards

vitamin D AEs

hypercalcemia, nausea, anemia, weakness

39
New cards

vitamin D contraindications

hypercalcemia, hypervitaminosis D

40
New cards

vitamin D dose

400-2000 units PO qd

41
New cards

vitamin D BBW

none

42
New cards

ferrous sulfate brand

feosol, fer-in-sol, slow fe, feratab

43
New cards

ferrous sulfate class

iron supplement

44
New cards

ferrous sulfate MOA

source of elemental iron

45
New cards

ferrous sulfate AEs

dyspepsia, nausea, vomiting, constipation, diarrhea, fecal discoloration

46
New cards

ferrous sulfate contraindications

hemolytic anemia, ulcerative colitis

47
New cards

ferrous sulfate dose

150-325 mg QD

48
New cards

ferrous sulfate BBW

none

49
New cards

folic acid brand

generic onl

50
New cards

folic acid class

vitamin

51
New cards

folic acid MOA

participates in DNA synthesis and erythropoiesis

52
New cards

folic acid AEs

nausea, abdominal pain, flatulence, irritability, rash

53
New cards

folic acid contraindications

none

54
New cards

folic acid dose

1 mg po qd

55
New cards

folic acid BBW

none

56
New cards

cyanocobalamin brand

vitamin b-12

57
New cards

cyanocobalamin class

vitamin

58
New cards

cyanocobalamin MOA

essential component and participant in physiologic systems

59
New cards

cyanocobalamin AEs

headache, nausea, anxiety, nervousness

60
New cards

cyanocobalamin contraindications

none

61
New cards

cyanocobalamin dose

1000 mcg SC/IV per month

62
New cards

cyanocobalamin BBW

none

63
New cards

lansoprazole brand

prevacid

64
New cards

lansoprazole class

ppi

65
New cards

lansoprazole moa

proton pump inhibition

66
New cards

lansoprazole AEs

increased incidence of osteoporosis-related bone fractures of the hip, spine, or wrist; may diminish the therapeutic effect of clopidogrel; increased risk of c diff

67
New cards

lansoprazole dose

15-30 mg po qd

68
New cards

lansoprazole contraindications

hepatic (consider dose adjustment with severe impairment)

69
New cards

lansoprazole BBW

none

70
New cards

dexlansoprazole brand

dexilant

71
New cards

dexlansoprazole class

ppi

72
New cards

dexlansoprazole moa

proton pump inhibition

73
New cards

dexlansoprazole AEs

increased incidence of osteoporosis-related bone fractures of the hip, spine, or wrist; may diminish the therapeutic effect of clopidogrel; increased risk of c diff

74
New cards

dexlansoprazole dose

healing: 60 mg po qd x up to 8 weeks maintenance: 30 mg po qd

75
New cards

dexlansoprazole contraindications

hepatic (consider dose adjustment with severe impairment)

76
New cards

dexlansoprazole BBW

none

77
New cards

pantoprazole brand

protonix

78
New cards

pantoprazole class

ppi

79
New cards

pantoprazole moa

inhibits gastric cell hydrogen-potassium ATPase

80
New cards

pantoprazole AEs

diarrhea, headache, abdominal pain, nausea, flatulence, dizziness, vertigo, myalgia

81
New cards

pantoprazole dose

20 mg PO/IV qd

82
New cards

pantoprazole contraindications

none

83
New cards

pantoprazole bbw

none

84
New cards

omeprazole brand

prilosec

85
New cards

omeprazole class

ppi

86
New cards

omeprazole moa

inhibits gastric cell hydrogen-potassium ATPase

87
New cards

omeprazole dose

20 mg PO qd

88
New cards

omeprazole AEs

diarrhea, headache, abdominal pain, nausea, flatulence, dizziness, rash, upper respiratory infection

89
New cards

omeprazole contraindications

none

90
New cards

omeprazole bbw

none

91
New cards

esomeprazole brand

nexium

92
New cards

esomeprazole class

ppi

93
New cards

esomeprazole moa

inhibits gastric cell hydrogen-potassium ATPase

94
New cards

esomeprazole AEs

diarrhea, headache, abdominal pain, nausea, vomiting, flatulence, dizziness

95
New cards

esomeprazole dose

20-40 mg PO QD

96
New cards

esomeprazole contraindications

none

97
New cards

esomeprazole bbw

none

98
New cards

famotidine brand

pepcid

99
New cards

famotidine class

histamine blocker (h2)

100
New cards

famotidine moa

antagonizes H2 histamine receptors